In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bigfoot Biomedical, Inc.

https://www.bigfootbiomedical.com/

Latest From Bigfoot Biomedical, Inc.

JPM Day 1: Abbott Riding In Tandem With Libre 2 Plus & t:slim X2 News

The two diabetes players announced a new integration between their products.

Diabetic Care Deals

No, I Am Spartacus – Embecta Joins The Quell Against GLP-1 Hype

Embecta, which recently completed its spin-off from Becton Dickinson, is forging ahead with its insulin injector-based business strategy, GLP-1s be damned. 

Diabetic Care Drug Delivery Technology

Senseonics See Few Barriers To Adoption For Their Implantable CGM

GLP-1 inhibitors and an ever-shrinking company ecosystem are not issues for the company, according to its CEO.

Diabetic Care Innovation

Abbott Buys Bigfoot Biomedical – But What Lurks In The Forest?

Abbott and Bigfoot Biomedical have worked as partners for more than half a decade but will now continue as one. Analysts are questioning whether the merger will simply be a tuck-in for Abbott, or enable it to release an insulin pump of their own.

M & A Diabetic Care
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Monitoring Equipment & Devices
  • Other Names / Subsidiaries
    • Asante Solutions, Inc.
    • Patients Pending Ltd
    • Timesulin
UsernamePublicRestriction

Register